Low PRDX1 protein and mRNA expression have been linked to improved survival and better prognosis in gastric cancer [61, 62], breast cancer [3, 63], and hepatocellular carcinoma [64], which was previously attributed only to the role of PRDX1 in redox signaling [3]. This evidence concerns the gene PRDX1 and breast carcinoma.